Supernus Pharmaceuticals reported $1.38B in Assets for its fiscal quarter ending in June of 2025.


Assets Change Date
Abbott USD 84B 2.55B Jun/2025
ANI Pharmaceuticals USD 1.34B 50.57M Jun/2025
Aurora Cannabis CAD 837.84M 28.68M Jun/2025
Bristol-Myers Squibb USD 94.68B 2.25B Jun/2025
Canopy Growth CAD 904.67M 259.55M Jun/2025
Corcept Therapeutics USD 801.72M 44.73M Jun/2025
Eisai JPY 1.41T 23.07B Jun/2025
Eli Lilly USD 100.92B 11.53B Jun/2025
Novo Nordisk 482.15B 7.01B Jun/2025
Pacira USD 1.54B 49.41M Jun/2025
Perrigo USD 10.09B 334.3M Jun/2025
Pfizer USD 206.1B 1.93B Jun/2025
Supernus Pharmaceuticals USD 1.38B 35.11M Jun/2025
United Therapeutics USD 7.91B 164.1M Jun/2025
Xeris Pharmaceuticals USD 334.69M 11.63M Jun/2025